These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 31679761

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L, Woodfield DG.
    N Z Med J; 1984 Oct 24; 97(766):719-21. PubMed ID: 6595558
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Transfusion of platelet concentrates].
    Rieux C, Lee K, Lavaud A, Bierling P.
    Ann Med Interne (Paris); 1999 Dec 24; 150(8):631-41. PubMed ID: 10686645
    [Abstract] [Full Text] [Related]

  • 27. Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.
    Stanworth SJ, Navarrete C, Estcourt L, Marsh J.
    Br J Haematol; 2015 Nov 24; 171(3):297-305. PubMed ID: 26194869
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion.
    Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekiguchi S.
    Vox Sang; 1989 Nov 24; 57(3):213-7. PubMed ID: 2617957
    [Abstract] [Full Text] [Related]

  • 30. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Leebeek FWG, Jansen AJG, Jongerius I, Zeerleder SS, Vidarsson G, Voorberg J, de Haas M.
    Haematologica; 2019 Feb 24; 104(2):403-416. PubMed ID: 30262558
    [Abstract] [Full Text] [Related]

  • 31. Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.
    Pappalardo PA, Secord AR, Quitevis P, Haimowitz MD, Goldfinger D.
    Transfusion; 2001 Aug 24; 41(8):984-7. PubMed ID: 11493728
    [Abstract] [Full Text] [Related]

  • 32. Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants.
    Jackman RP, Deng X, Bolgiano D, Lebedeva M, Heitman JW, Busch MP, Slichter SJ, Norris PJ.
    Blood; 2013 Apr 18; 121(16):3261-6; quiz 3299. PubMed ID: 23393051
    [Abstract] [Full Text] [Related]

  • 33. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep 18; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 34. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C, Linjama T, Edgren G, Lauronen J, Wikman A, Höglund P.
    Transfusion; 2019 Mar 18; 59(3):945-952. PubMed ID: 30575964
    [Abstract] [Full Text] [Related]

  • 35. Platelets Structure, Function and Modulator Capacity in Replacement Therapy.
    Moutinho B, Pinto B, Cardoso R, Botelho MC.
    Cardiovasc Hematol Disord Drug Targets; 2017 Mar 18; 17(3):180-184. PubMed ID: 29283062
    [Abstract] [Full Text] [Related]

  • 36. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb 18; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 37. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S, Maier F, Höcker P, Mayr WR, Hinterberger W.
    Infusionsther Klin Ernahr; 1987 Apr 18; 14 Suppl 2():10-4. PubMed ID: 3298059
    [Abstract] [Full Text] [Related]

  • 38. Platelet transfusion for patients with cancer.
    Fletcher CH, DomBourian MG, Millward PA.
    Cancer Control; 2015 Jan 18; 22(1):47-51. PubMed ID: 25504278
    [Abstract] [Full Text] [Related]

  • 39. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H, Bertrand G, Zitouni S, Djenouni A, Martageix C, Griffi F, Kaplan C, Ouelaa H.
    Transfus Apher Sci; 2015 Jun 18; 52(3):295-9. PubMed ID: 25620758
    [Abstract] [Full Text] [Related]

  • 40. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions.
    Abraham AS, Chacko MP, Fouzia NA, Srivastava A, Daniel D.
    Transfus Med; 2018 Oct 18; 28(5):392-397. PubMed ID: 29460307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.